North Macedonia vs World: Percentage of bloodstream infection due to Escherichia coli resistant
North Macedonia
60.0%
in 2022
World
44.7%
in 2022
North Macedonia rank
11th
World rank
11th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- North Macedonia
- World
How they compare
North Macedonia currently reports 60.0% against 44.7% in World, a difference of 15.3%.
That makes North Macedonia's figure about 1.3 times World's.
Across all 7 years both countries report, North Macedonia has been ahead every year.
North Macedonia ranks 11th and World ranks 11th of 50 countries.
North Macedonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | North Macedonia | World | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 72.0% | 43.5% | 28.5% | North Macedonia |
| 2020s | 65.6% | 43.8% | 21.9% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, North Macedonia or World?
- North Macedonia, at 60.0% against 44.7% in World as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between North Macedonia and World?
- 15.3%, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and World?
- 7 years are reported by both, from 2016 to 2022.
- How do North Macedonia and World rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- North Macedonia ranks 11th and World ranks 11th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.